Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02647905 · ClinicalTrials.gov registry record · NA
Evaluation of the Accuracy of an Implanted Glucose Sensor
A NA study, sponsored by Senseonics.
- Completed
- Registry status
- NA
- Development phase
- 90
- Enrollment target
NCT02647905 is a NA study that has completed, run by Senseonics. The registered enrollment target is 90 participants.
The verdict
NCT02647905, a NA study, has completed, sponsored by Senseonics.
- COMPLETED
- Registry status
- NA
- Development phase
- 90 participants
- Enrollment target
Study Summary
The purpose of this clinical investigation is to evaluate the accuracy of the Senseonics Continuous Glucose Monitoring System (Senseonics CGM System) measurements when compared with reference standard measurements The investigation will also evaluate safety of the Senseonics CGM System usage.
Interventions
- DEVICE Continuous Glucose Monitoring System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 90 participants |
| Start Date | 2016-01 |
| Est. Completion | 2016-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02647905
The ClinicalTrials.gov registry entry for NCT02647905 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 90 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Senseonics, which has 7 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Continuous Glucose Monitoring System is the first listed.
NCT02647905 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02647905 about?
NCT02647905 is a clinical study titled "Evaluation of the Accuracy of an Implanted Glucose Sensor". The purpose of this clinical investigation is to evaluate the accuracy of the Senseonics Continuous Glucose Monitoring System (Senseonics CGM System) measurements when compared with reference standard measurements The investigation will also evaluate safety of the Senseonics CGM System usage.
What is the current status of trial NCT02647905?
This trial is currently completed. It is a NA study. The enrollment target is 90 participants. The study started on 2016-01. Estimated completion is 2016-07.
What interventions are being tested in trial NCT02647905?
The interventions under investigation include: Continuous Glucose Monitoring System (DEVICE).
Who is sponsoring clinical trial NCT02647905?
This trial is sponsored by Senseonics, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.